Ocean Biomedical, Inc.
OCEA · NASDAQ
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Market Cap | $4 | $39 | $69 | $83 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $9 | $16 | $13 | $11 |
| Enterprise Value | $13 | $55 | $82 | $94 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$8 | $1 | -$5 | -$17 |
| % Margin | – | – | – | – |
| Net Income | -$8 | $0 | -$6 | -$17 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.3 | 0.01 | -0.2 | -0.63 |
| % Growth | -3,100% | 105% | 68.3% | – |
| Operating Cash Flow | -$0 | -$3 | -$1 | -$0 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$0 | -$3 | -$1 | -$0 |